Novavax had a deal in place with Serum Institute of India for 1bn doses / year.
- Its now agreed with the lab firm for 2 bn doses / year.
When a vaccine is approved, of course.
production will be for low- and middle-income countries and India.
When a vaccine is approved, of course.
production will be for low- and middle-income countries and India.
Most Popular
Sponsored
AI boom fuels US GDP growth! Business investment outpaces consumer spending, with tech giants boosting capex projections.
SNDK reporting tonight. Will the beast continue or correct?
IONQ's revenue soars 429% on quantum tech wins; potential for huge returns, but risk remains.
BioticsAI's AI ultrasound tool gains FDA nod, de-risking its path to market. Early $100k build shows capital efficiency.
GM's connected services show 70% subscriber growth & $5.8B deferred revenue, boosting margins & valuation.
BYD's 17x P/E & 23% net income CAGR vs. QS's 42x 2028 sales valuation. EV growth is cooling but expected to rebound.
Kimco's FFO jumps 4.5% on strong leasing spreads (23.8%) & rising NOI. Valuations show a discount vs. private markets.
Sponsored
Must Read